Denali Therapeutics Inc (DNLI)

CapEx to Revenue

94.81%

TTM · Retrieved:

DNLI logo

DNLI CapEx to Revenue

Current (TTM)94.81%
DNLI TTM CapEx/Revenue (94.81% → 94.81%)
More history is needed to export this chart.

DNLI capex to revenue history

Published TTM snapshot. The date records when this current TTM value was retrieved.

Denali Therapeutics Inc CapEx to Revenue — Published TTM snapshot
RetrievedCapEx to Revenue
94.8113%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.